25 26 BK polyomavirus (BKPyV) is a human pathogen first isolated in 1971. BKPyV infection is ubiquitous in the 27 human population, with over 80% of adults worldwide being seropositive for BKPyV. BKPyV infection is 28 usually asymptomatic; however, BKPyV reactivation in immunosuppressed transplant patients causes 29 two diseases, polyomavirus-associated nephropathy and hemorrhagic cystitis. To establish a successful 30 infection in its host cells, BKPyV must travel in retrograde transport vesicles to reach the nuclei. To make 31 this happen, BKPyV requires the cooperation of host cell proteins. To further identify host factors 32 associated with BKPyV entry and intracellular trafficking, we performed a whole-genome siRNA screen 33 on BKPyV infection of primary human renal proximal tubular epithelial cells. The results revealed the 34 importance of the Ras-related protein Rab18 and syntaxin 18 for BKPyV infection. Our subsequent 35 experiments implicated additional factors that interact with this pathway, and suggest a more detailed 36 model of the intracellular trafficking process, indicating that BKPyV reaches the ER lumen through a 37 retrograde transport pathway between the late endosome and the ER. 38 39
Introduction 46
and was first isolated in 1971 (1). Subsequent serology surveys have revealed that up to 80% of the contain BKPyV traffic along microtubules and reach the ER at 8-12 hours post infection (17, 19) . ER 77 lumen proteins are essential for polyomavirus disassembly and egress from the ER (9, 17, (20) (21) (22) . Briefly, 78 protein disulfide isomerases induce capsid conformational changes and minor capsid protein exposure 79 (17, 23-28). These exposed minor proteins insert into the ER membrane (29, 30), and partially 80 disassembled polyomaviruses penetrate the ER membrane and enter the cytosol through the 81 endoplasmic reticulum-associated degradation pathway (9, 20, 21, 31, 32) . In the cytosol, the nuclear 82 localization signal of the minor capsid proteins guides polyomaviruses into the nucleus via the importin 83 α/β pathway (33) (34) (35) . In addition to this productive model of entry, a significant portion of internalized 84 polyomavirus enters a non-productive pathway (36). Distinguishing the critical events that BKPyV takes 85 to establish successful infection from other pathways that BKPyV takes remains a challenge. 86
Numerous assays have been developed for the purpose of identifying host factors associated with viral 87 infections, including genome-wide siRNA screening. By silencing every single human gene with an siRNA 88 pool, and then assessing the effects of the knockdown on infection, it is feasible to dissect the functions 89 of individual host proteins during the viral life cycle. siRNA screening has been extensively applied to 90 research on viruses, such as HIV (37), West Nile Virus (38), HPV (39), VSV (40) , and another 91 polyomavirus, SV40 (41). However, no genome-wide siRNA screen has been reported for BKPyV. 92
Using a whole genome siRNA screen, we have identified a series of potential host factors that are 93 involved in BKPyV infection. DNAJ B14, which has previously been implicated in BKPyV entry, is our top 94 hit, and DNAJ B12 is also among our top 100 hits (21, 41) . Most of the other hits we have identified have 95 not been previously reported, however, and many of them are involved in vesicular transport. In this 96 report, we present data showing that two of our primary hits, Rab18 and syntaxin 18, as well as two 97 members of the NRZ complex (RAD50 interactor 1 and ZW10 kinetochore protein), which have 98 previously been shown to interact with Rab18 and syntaxin 18, are essential host factors for BKPyV 99 infection. 100
Results 101
A high-throughput siRNA screen on BKPyV based on cell cycle analysis 102
To identify host factors involved in viral entry and intracellular trafficking, we developed and 103 implemented a high-throughput whole-genome siRNA screen for BKPyV infection in its natural host cell, 104 primary human renal proximal tubule epithelial (RPTE) cells. In this screen, BKPyV infection was 105 challenged with the Dharmacon siGENOME Smartpool siRNA library, which includes more than 18,000 106 human siRNA pools. Each pool contains four unique siRNAs that target the same host gene. The screen 107 was performed in triplicate. Every screen plate included the siGENOME non-targeting control (NTC) as a 108 negative control and a synthetic siRNA which corresponds to the natural BKPyV 5p miRNA targeting the 109 large tumor antigen (TAg) mRNA (siTAg) (42), as a positive control. 110
Our lab previously showed that BKPyV induces G2/M arrest to take full advantage of the host DNA 111 replication machinery (43); this provided us with a cost-efficient approach to evaluate viral infection in 112 siRNA-transfected cells. By applying a Hoechst DNA stain, cells in G2/M phase are distinguishable from 113 the rest of the cells based on the difference in DNA content in each nucleus. The percentage of G2/M 114 arrested cells (G2%) dramatically increases after BKPyV infection, and we adopted it as the readout for 115 the screening assay. 116
For the primary screen, RPTE cells were transfected with the siRNA library and cultured for 48 hours to 117 allow depletion of the targeted proteins. Next, cells were infected with BKPyV and cultured for an 118 additional two days. The cells were fixed and stained with Hoechst, and the numbers of nuclei in the 119 different stages of the cell cycle were quantified, recorded, and uploaded to the MScreen web tool 120 developed by the Center for Chemical Genomics (University of Michigan) (44). G2% values were 121 calculated using the MScreen web tool. To proceed with the data analysis, we scaled data from 0 to 100, 122 with 100 representing the effect of our positive control, and 0 representing the effect of negative 123 control. The effect of each siRNA pool was then calculated using this index scale. A larger index value 124 represents a stronger inhibitory effect on the BKPyV infection when an siRNA pool is introduced into 125 DAVID analysis showed that translation-related genes were the most enriched group of genes that is 137 required for viral infection among the candidate genes (Supplemental Table 1 
, Sheet2). Considering that 138
BKPyV exclusively relies on the host protein synthesis machinery, this result is consistent with our 139 expectation. Other than translation-related genes, several clusters of genes that are required for viral 140 infection were also significantly enriched, especially budding and coat proteins associated with vesicular 141 transport. Based on the enrichment analysis results, we manually selected 147 siRNA pools for 142 secondary validation. 143 G2% is an indirect readout for BKPyV infection. Knocking down cell cycle regulatory proteins may also 144 affect G2/M arrest independent of viral infection; thus false positive or false negative candidates could 145 be introduced into the results during the primary screen. To eliminate these false candidates, we next 146 applied a direct readout, immunofluorescent staining for the early viral protein TAg, to validate these 147 147 genes. RPTE cells were transfected and infected in 96 well plates with a subset of the siGENOME 148 library that contains the selected 147 siRNA pools. Infected cells were fixed at 48 hours post infection 149 and probed for TAg with primary antibody and FITC-labeled secondary antibody. After acquiring images, 150 the integrated TAg fluorescent intensity per nucleus was recorded, and the inhibition index was 151 calculated as in the primary screen (Supplemental Table 2 ). 152
After the secondary screen, DNAJ B14, which has previously been implicated in BKPyV entry, was our 153 top hit, and DNAJ B12 and DNAJC3, which are also involved in polyomavirus trafficking, were also among 154 our top ten hits (21, 41), which indicates the overall robustness of our screen. Rab18 was one of our top 155 validated hits other than these DNAJ proteins. Moreover, syntaxin 18, a protein that has previously been 156 demonstrated to interact with Rab18, also passed our validation. 157
158
The Rab18/NRZ/syntaxin 18 complex is required for BKPyV infection 159
The Rab protein family is a group of small GTPases that regulate membrane trafficking, and that have 160 been implicated in polyomavirus intracellular trafficking (14, 18, 48). Rab18, however, had not 161 previously been associated with polyomavirus infection. The Rab18 interaction network has been 162 thoroughly investigated (49), and more than 40 proteins have been identified as interacting with Rab18. 163 Among these proteins, syntaxin 18 was also one of our top hits in the screen. 164
To determine whether Rab18 and syntaxin 18 are required during BKPyV infection, RPTE cells in 12 well 165 plates were transfected with pooled or individual siRNAs targeting these proteins. Cells transfected with 166 the NTC siRNA pool and siTAg served as negative and positive controls, respectively. After transfection, 167 cells were cultured for two days to allow for depletion of the targeted proteins, and then infected with 168
BKPyV at a multiplicity of infection (MOI) of 1 infectious unit (IU)/cell. Cells were lysed at 48 hours post 169 infection, and expression of the targeted proteins, TAg, and β-actin or glyceraldehyde 3-phosphate 170 dehydrogenase (GAPDH) were assessed by Western blotting (Figure 2A In addition to syntaxin 18, Rab18 interacts with ZW10 kinetochore protein (ZW10) and RAD50 Interactor 178 1 (RINT1), which together with neuroblastoma amplified gene (NAG) are members of the NRZ complex 179 (51). Upon activation by GTP, Rab18 interacts with the ZW10 kinetochore protein from the NRZ 180 complex, thereby forming a Rab18/NRZ/syntaxin 18 complex at the ER (49). In this complex, syntaxin 18 181 functions as a t-SNARE on the ER membrane where the NRZ components work as a tether to assist with 182 retrograde vesicle docking (51, 52). NRZ/syntaxin 18 cooperate in capturing Rab18-labeled vesicles and 183 initiating the fusion process on the ER membrane. Although none of the NRZ complex proteins were 184 identified in our primary screen, we hypothesized that they are required for BKPyV infection due to their 185 ability to interact with both Rab18 and syntaxin 18. To test whether NRZ components are involved in 186
BKPyV infection, we knocked down RINT1 and ZW10, followed by infection. We could not test NAG due 187 to lack of a useful antibody to measure its expression. The Western blot results indicate that disrupting 188 the NRZ complex by knocking down these two components interferes with infection ( Figure 2B However, the non-reducing gel suggests that the BKPyV particle could not disassemble efficiently 214 without Rab18 ( Figure 4A , top panel). The reducing gel shows that equal amounts of VP1 are detectable 215 in the presence or absence of Rab18, indicating that knocking down Rab18 did not prevent BKPyV from 216 attaching to or entering RPTE cells. We also assessed the effect of knocking down RINT1, ZW10, and 217 syntaxin 18 on BKPyV disassembly ( Figure 4A , bottom panel). In each case, lower amounts of VP1 218 monomers and dimers were detected in the non-reducing gel, suggesting that BKPyV cannot 219 disassemble efficiently without the help of the NRZ complex. 220
Previous studies showed that mouse polyomavirus (MPyV) could enter cells that do not produce proper 221 ganglioside receptors; afterward, these MPyV particles are trapped in a dead-end pathway and cannot 222 establish a successful infection. This indicates that polyomaviruses enter both productive and non-223 productive pathways inside host cells. These non-productive pathways result in a diffuse distribution of 224 viral particles as detected by immunofluorescent staining (36). In the presence of proper ganglioside 225 receptors, polyomaviruses leave the cell periphery, move along microtubules, and reach the perinuclear 226 area (17, 19, 55, 56). Ultimately, the productive pathway leads to the ER (17, 28, 57). Since we saw that 227
BKPyV could not reach the ER lumen without Rab18 while the entry of BKPyV was not affected ( Figure  228 4A), we wished to address if BKPyV traffics in a different pattern under Rab18 knockdown. To test this, 229
Rab18 was depleted as previously described, and RPTE cells were infected with BKPyV at MOI of 5. Cells 230 were fixed and stained for VP1 at 24 hours post infection ( Figure 4B ). In the presence of Rab18, BKPyV 231 forms bright foci in the perinuclear area as previously observed (9). However, Rab18 knockdown caused 232 dispersion of the bright perinuclear VP1 foci, and the staining of VP1 appeared to be diffuse and spread 233 throughout the cytoplasm ( Figure 4B ). Thus, without Rab18 BKPyV traffics in a pattern that is suggestive 234 of a non-productive pathway (36). 235
236
BKPyV is enriched in the late endosome without Rab18. 237
Our previous study demonstrated that acidification of the endosome is essential for BKPyV infection 238 (17), and MPyV colocalizes with the late endosome marker Rab7 after entry (18). Furthermore, BKPyV 239 cannot traffic efficiently to the ER and initiate capsid disassembly without abundant Rab18 and instead 240 appears to be trapped in an unknown compartment(s) diffusely located in the cytoplasm (Figure 4 ). To 241 identify this compartment, we knocked down Rab18 in RPTE cells, fixed cells at 24 hours post infection, 242 and probed for various organelle markers ( Figure 5 ). We found that the diffuse viral particles do not 243 colocalize with the early endosome marker EEA1, cis-Golgi marker GM130 (58), or trans-Golgi marker 244
Golgin 97 (59). On the other hand, we found that the VP1-rich area overlaps with Rab7. To further 245 confirm this colocalization, images of VP1 and Rab7 were taken using confocal microscopy ( Figure 6 ). 246
We found that the dispersed VP1 partially colocalizes with Rab7 when Rab18 is knocked down, 247
suggesting some viral particles are trapped in the late endosome in the absence of Rab18. There is also 248 some VP1 that does not colocalize with Rab7. This may be a result of asynchronous trafficking of BKPyV, 249 and additional intermediate and dead-end compartments could also exist during the retrograde 250 trafficking step between the endosome and the ER. Our results suggest that BKPyV reaches ER lumen 251 through a Rab18-mediated retrograde transport pathway between the late endosome and the ER. The percentage of cells in G2/M phase provided us a cost-efficient assay for the primary screen. Our 276 primary screen results indicated that knocking down 70% of the human genes in RPTE cells inhibited 277 BKPyV infection to some degree when compared to the non-targeting control. A similar data distribution 278 was also observed in an siRNA screen for HPV infection using the same siRNA library (39). We found that 279 the NTC siRNA reproducibly slightly increased BKPyV infection compared to the no siRNA control. This 280 could be because of interference of exogenous siRNA with the host intrinsic miRNA processing and 281 silencing mechanism. BKPyV encodes a miRNA that downregulates TAg mRNA levels (42, 69). If the 282 introduction of exogenous siRNA affects the miRNA processing and silencing mechanism, TAg expression 283 would increase due to lower levels of the mature BKPyV miRNA. 284
The increased BKPyV infection induced by the non-targeting siRNA control could also be an off-target 285 effect of RNAi. While validating our primary screening results, we found many of our primary hits were 286 not reproducible when tested with individual siRNAs instead of siRNA pools. It appears that off-target 287 effects of RNAi are inevitable for whole genome siRNA screens, and an 'ideal non-targeting' siRNA pool 288 does not exist (70). The most likely cause of the off-target effect is the passenger strand of the siRNA. 289
Each siRNA carries a complimentary strand (passenger strand) to enhance the stability of the siRNA 290 molecules. This passenger strand can also be integrated into the RNA-induced silencing complex (RISC), 291 which possibly increases off-target effects. Moreover, even if only the guide strand enters the RISC 292 complex, RISC prefers the 2nd to the 8th nucleotides of that strand, called the seed region, to recognize 293 targeted mRNAs (70-74). Considering this characteristic of RNAi, each seven-nucleotide seed region can 294 target more than one gene. Off-target effects can therefore increase the expense of validation and 295 lower the efficiency of screening. 296
After validating some of the top hits as well as other genes that are known to be involved in the same 297 vesicular trafficking pathway, Rab18, syntaxin 18, ZW10, and RINT1 were confirmed as essential host 298 factors for BKPyV infection. Rab18 has been associated with lipid droplet homeostasis and vesicular 299 transport between the Golgi apparatus and the ER (53, 54). The majority of Rab18 usually localizes to 300 the membrane of the ER and the cis-Golgi apparatus (53). Also, Rab18 is recruited to the surface of lipid 301 droplets, the endosome, and the lysosome (75, 76). Rab18 has been shown to interact with syntaxin 18, 302 ZW10, and RINT1 by affinity chromatography followed by mass spectrometry (49). Based on previous 303 studies on yeast proteins, ZW10 and RINT1 interact with each other via their N-termini and interact with 304 the NAG protein to form the NRZ complex. The t-SNARE protein syntaxin 18 on the ER membrane 305 indirectly attaches to the NRZ complex (51, 52, 77). The overall structure of the NRZ complex is a 306 protrusion about 20 nm in length from the surface of the ER membrane (78). GTP-activated Rab18 on 307 the surface of vesicles interacts with ZW10, thereby tethering vesicles to the ER membrane. Syntaxin 18 308 is a SNARE protein and mediates vesicle fusion to the ER (50). After the NRZ complex captures vesicles, 309 syntaxin 18 mediates vesicle fusion with the ER membrane. 310
We propose a model of BKPyV entry and intracellular trafficking to the ER based on previous findings 311 and our current results (Figure 7) . To initiate infection, BKPyV first binds to its ganglioside receptors 312 GT1b and GD1b (10). After initial attachment, BKPyV is believed to form deep invaginations of the host 313 plasma membrane in the same manner as SV40 (79). The length of ceramide tails of the ganglioside 314 plays a critical role in formation of the invagination (79). Next, BKPyV enters host cells via a ganglioside-315 dependent, caveolin-and clathrin-independent pathway (12, 80). Meanwhile, glycoproteins on the 316 plasma membrane appear to serve as traps for polyomavirus (81): viral particles that bind to 317 glycoproteins will eventually enter non-productive pathways. Only those particles that bind to the 318 correct ganglioside receptor can enter the productive infection pathway (36). Furthermore, binding to 319 the gangliosides is sufficient to drive transport of artificial particles to the ER (18). This indicates that 320 binding to the proper ganglioside is both necessary and sufficient for BKPyV to traffic in retrograde 321 transport vesicles to the ER. In addition, conformational changes of the capsid are neither required nor 322 observed before polyomaviruses enter the ER lumen (27, 28). These findings reveal that BKPyV may 323 remain bound to the membrane throughout the intracellular trafficking until reaching the ER lumen. Gangliosides have been demonstrated to be important for rotavirus infection (90), and rotavirus also 346 traffics to and is sorted through the endosome (91). However, details of the Rab18-mediated pathway 347 are largely unknown, and further efforts will be needed to fully reveal the details of this retrograde 348 trafficking pathway. 349
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We would like to thank the members of the Imperiale Lab, past and present, for their support and Infection. BKPyV (Dunlop) was cultured, purified on a cesium chloride linear gradient, and titered as 368 described previously (17, 92). RPTE cells were infected as follows at two days post siRNA transfection. 369
Cells were pre-chilled for 15 min at 4˚C. Purified viruses were diluted to 175,000 IU/ml (MOI 1) or 370 875,000 IU/ml (MOI 5) in REBM/REGM. 400 μl of the diluted virus were added to the wells of a 12 well 371 plate and incubated at 4˚C for 1 hour with shaking every 15 minutes to distribute the inoculum over the 372 entire well. The plate was transferred to 37˚C after the 1-hour incubation. 373 siRNA and siRNA library. The whole-genome human siGENOME smart pool siRNA library from 374
Dharmacon was acquired and prepared by the Center for Chemical Genomics (University of Michigan). 375
All other siRNAs were also purchased from Dharmacon: Non-targeting siRNA control (D-001206-14); 376
Rab18 siRNA (LQ-010824-00); STX18 siRNA (LQ-020624-01); ZW10 siRNA (LQ-003948-00); RINT1 siRNA 377 (LQ-004976-01); siRNA targeting large T antigen (custom synthesized with the sequence 5' 378 AUCUGAGACUUGGGAAGAGCAU 3'), which corresponds to the natural BKPyV 5p miRNA (42). 2% milk in PBS-T as follows: TAg (pAb416) at 1:5,000 dilution (93); syntaxin 18 (Abcam, ab156017) 430 diluted in 5% BSA at 1:1,000; Rab18 (MilliporeSigma, SAB4200173) at 1:10,000; VP1(pAb5G6) 1:1000; 431 GAPDH (Abcam, ab9484) at 1: 10,000; ZW10 kinetochore protein (Abcam, ab53676) at 1:300; RAD50 432 interactor 1 (MilliporeSigma, HPA019875) at 1:200; β-actin (Cell signaling, #4967) at 1:10,000; 433 horseradish peroxidase (HRP)-conjugated ECL sheep anti-mouse (GE healthcare, NA931V) at 1: 5,000; 434 and HRP-conjugated ECL donkey anti-rabbit antibody (GE Healthcare, NA934V) at 1: 5,000. Protein 435 bands were visualized with HRP substrate (Millipore, WBLUF0100) and exposure to X-ray film or the 436 Syngene PXi gel doc system. 437
Immunofluorescent staining. 18 mm circular coverslips (#1.5 thickness, Electron Microscopy Sciences, 438 72222) were coated with 0.1% poly-L-lysine in water (MilliporeSigma, P8920) in 12 well plates for 5 min 439 at room temperature. Coverslips were then rinsed with cell culture grade water and allowed to dry for 440 at least 2 hours. RPTE cells were then seeded onto the coverslips in the 12-well plate. For processing, 441 the cells were fixed with 4% PFA at room temperature for 20 min. Antigen was retrieved with antigen 442 retrieval buffer (100 mM Tris, 5% [w/v] urea, pH 9.5) at 95 ˚C for 10 min. Cell membranes were 443 permeabilized with 0.1% Triton X-100 in PBS at room temperature for 5 min. Coverslips were blocked 444 with 5% goat serum in PBS for 1 hour and probed with diluted primary and secondary antibody 445 successively, 1 hour each. Coverslips were washed with PBS for three times between each step. Lastly, 446 coverslips were mounted with Prolong Gold Reagent with DAPI (Thermo Fisher Scientific, P36931 
